News

A Zika virus vaccine has protected mouse fetuses against brain infections and malformations, warranting further exploration as a vaccine candidate.

Patient-specific tumor ‘organoid’ models have been developed to identify the most effective treatment for each appendix tumor.

Black men diagnosed with prostate cancer classified as low risk may actually have a more aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests.

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

Three new strains of hepatitis C have been found circulating in the general population in sub-Saharan Africa, suggesting that certain antiviral drugs currently used in the West may not be as effective against the new strains.

Inexpensive 3-D-printed microfluidics device could be used to personalize cancer treatment. A key feature in this MIT-designed device was using a new biocompatible resin — traditionally used for dental applications — that can support long-term survival of biopsied tissue.

Giving a probiotic supplement to pregnant mothers and their infants significantly reduces the chances of a child developing eczema for the first 11 years of their life.

An experimental vaccine strategy against HIV has been shown to work in non-human primates.

Surveillance of hospitalized cases of laboratory-confirmed influenza showed an effectiveness of influenza vaccination in reducing ICU admission or death.

Scientists have discovered the signals that determine the fate of immature cells in the pancreas. The research shows that they are very mobile and that their destiny is strongly influenced by their immediate environment.